{"id":23630,"date":"2022-03-24T09:32:26","date_gmt":"2022-03-24T09:32:26","guid":{"rendered":"https:\/\/celonpharma.com\/?p=23630"},"modified":"2025-04-04T12:53:12","modified_gmt":"2025-04-04T12:53:12","slug":"february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/","title":{"rendered":"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Legal basis: Article 56 section 1 point 2 Act on Public Offering \u2013 current and periodic information.<br>Date: February 16, 2022.<br>The abbreviated name of the issuer CELON PHARMA S.A.<br>Subject: The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Management Board of Celon Pharma SA (the &#8220;Company&#8221;) hereby informs about the statement issued by the Central Securities Depository of Poland (&#8220;KDPW&#8221;), on February 15, 2022, on conclusion of an agreement with the Company on the registration of securities in the depository of up to 2,000,000 series C shares of the Company.<br>Th shares will be registered on the basis of settlement orders referred to in \u00a7 6 of the Specific Operating Rules, in connection with deregistration of subscription warrants which were used to exercise the rights of the above-mentioned shares.<br>Series C shares are issued as part of the contingent capital, pursuant to Resolution No. 7\/2021of the General Meeting of Shareholders of February 16, 2021 (current report No. 9\/2021).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Legal basis: Article 56 section 1 point 2 Act on Public Offering \u2013 current and periodic information.Date: February 16, 2022.The abbreviated name of the issuer CELON PHARMA S.A.Subject: The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares The Management Board of Celon Pharma SA (the &#8220;Company&#8221;) hereby informs<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/\" title=\"ReadFebruary 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-23630","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company&#039;s series C shares - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company&#039;s series C shares - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"Legal basis: Article 56 section 1 point 2 Act on Public Offering \u2013 current and periodic information.Date: February 16, 2022.The abbreviated name of the issuer CELON PHARMA S.A.Subject: The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares The Management Board of Celon Pharma SA (the &#8220;Company&#8221;) hereby informsRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-24T09:32:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-04T12:53:12+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/\",\"url\":\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/\",\"name\":\"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company's series C shares - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2022-03-24T09:32:26+00:00\",\"dateModified\":\"2025-04-04T12:53:12+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company's series C shares - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/","og_locale":"en_US","og_type":"article","og_title":"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company's series C shares - CelonGROUP","og_description":"Legal basis: Article 56 section 1 point 2 Act on Public Offering \u2013 current and periodic information.Date: February 16, 2022.The abbreviated name of the issuer CELON PHARMA S.A.Subject: The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares The Management Board of Celon Pharma SA (the &#8220;Company&#8221;) hereby informsRead more &raquo;","og_url":"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/","og_site_name":"CelonGROUP","article_published_time":"2022-03-24T09:32:26+00:00","article_modified_time":"2025-04-04T12:53:12+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/","url":"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/","name":"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company's series C shares - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2022-03-24T09:32:26+00:00","dateModified":"2025-04-04T12:53:12+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2022\/03\/24\/february-16-2022-current-report-no-4-2022-the-kdpw-statement-on-concluding-an-agreement-on-the-registration-of-the-companys-series-c-shares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"February 16, 2022 \u2013 Current Report No. 4\/2022 \u2013 The KDPW statement on concluding an agreement on the registration of the Company&#8217;s series C shares"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/23630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=23630"}],"version-history":[{"count":1,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/23630\/revisions"}],"predecessor-version":[{"id":40207,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/23630\/revisions\/40207"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=23630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=23630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=23630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}